GET A VALUABLE CERTIFICATE FOR JOB MARKET


ACADEMIC RECOGNITION OF 3 OR 6 CREDITS


DESIGNED FOR EXPERTS BY EXPERTS


IDENTIFYING SUSCEPTIBILITY FOR ADVERSE DRUG REACTIONS


OBJECTIVES



To understand effect modification

To understand the principles of genetic susceptibility for drug risks

Pharmacogenetics, pharmacogenomics, effect modification

 

MODULE PARTS



  1. Introduction, risk factors and effect modification
  2. Variability in drug response and principles of pharmacogenetics/pharmacogenomics
  3. Assessment of pharmacogenetic influence through candidate genes and genome-wide association studies (GWAS)
  4. Ongoing initiatives and biological interpretation
  5. Successes and failures in pharmacogenetic studies

 

TRAINER TEAM



Coordinator: Prof Bruno Stricker (from Erasmus Universitair Medisch Centrum)

Expert(s): Dr Peter Rijnbeek, Dr Maris Kuningas, Dr Loes E. Visser, Dr Teun Van Gelder, Prof Cornelia M. Van Duijn, Dr Ron Van Schail, Prof André G Uitterlinden (from Erasmus Universitair Medisch Centrum), Prof Anke-Hilse Maitland-Van Der Zee (from Utrecht Universiteit).

Advanced level
75 h workload over 3 months (3 ECTS credits)
Key dates
Course calendar
Certificate award
or included in Master Year 2 or PhD programme
English language
Online based learning
Student: 1,500 €
Professional: 3,000 €
  Savings could be offered under eligibility conditions.

Applications currently closed

Application to this training will be available
from June 19th, 2017 to March 23rd, 2018.
Thanks for applying during this period.

Contact the Eu2P Central Office

Applications will open on June 19th, 2017. Please contact the Eu2P Central Office for information.

Or include this module in your training curriculum choices...

Master Year 2 PhD



Confused? Read the FAQs...

NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners